Leading Pathologists to Showcase First Case Studies with Oncomine Dx Target Test at Association for Molecular Pathology Annual Meeting

Leading Pathologists to Showcase First Case Studies with Oncomine Dx Target Test at Association for Molecular Pathology Annual Meeting Thermo Fisher Scientific customers also highlight their latest research advancements in solid tumor profiling and liquid biopsy analysis during corporate workshops CARLSBAD, Calif. and SALT LAKE CITY, Nov. 14, 2017 /PRNewswire/ — Advances in next-generation sequencing (NGS)... Read more

Bio-Techne Awards 40,000 USD Research Grant to Innovative Cancer Researcher

NOVEMBER 14, 2017 Melbourne-based melanoma researcher selected as the winner of ‘RNAscope ISH Get Hybridized’ giveaway, supporting cutting-edge research MINNEAPOLIS, Nov. 14, 2017 /PRNewswire/ — Advanced Cell Diagnostics (ACD), a Bio-Techne brand, has announced the winner of its ‘RNAscope ISH Get Hybridized’ giveaway, designed to recognize and support groundbreaking research with RNAscope® in situ hybridization (ISH) technology. The winner,... Read more

Announcing the winner of the 2017 Sir Martin Wood Prize for Japan

13 November 2017 Oxford Instruments is delighted to announce Dr Michihisa Yamamoto from the Quantum-Phase Electronic Center, The University of Tokyo, and Center of Emergent Matters, RIKEN, Japan as the winner of the 2017 Sir Martin Wood Prize. Dr Yamamoto was awarded the prize for his work on the “Control and detection of quantum phase... Read more

Brooks Automation to Present at the Stifel 2017 Healthcare Conference

CHELMSFORD, Mass., Nov. 13, 2017 (GLOBE NEWSWIRE) — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that the company will present at the Stifel 2017 Healthcare Conference at the Lotte New York Palace Hotel, New York. Steve Schwartz, President and Chief Executive Officer and Lindon Robertson, Chief Financial Officer, will present on Tuesday, November 14th at 8:45... Read more

Agilent Thought Leader Award Presented to Renowned Drug Discovery Researcher Professor Jiandong Jiang

Agilent Thought Leader Award Presented to Renowned Drug Discovery Researcher Professor Jiandong Jiang Award to Chinese Scientist Supports the Use of Various Molecular Approaches to Cancer Research SANTA CLARA, Calif., November 12, 2017 Agilent Technologies Inc. (NYSE: A) today announced that Professor Jiandong Jiang has received an Agilent Thought Leader Award in support of his... Read more

Thermo Fisher Scientific Earns Perfect Score on Corporate Equality Index

WALTHAM, Mass., Nov. 9, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, received a perfect score of 100 on the 2018 Corporate Equality Index (CEI), the Human Rights Campaign Foundation’s 16th annual scorecard on lesbian, gay, bisexual, transgender and queer (LGBTQ) workplace equality. This is the third consecutive year that Thermo... Read more

Illumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding Decades of Leadership Experience in Healthcare

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that Gary S. Guthart will join the company’s Board of Directors on December 1, 2017. Dr. Guthart is President and Chief Executive Officer of Intuitive Surgical, a global leader in the field of robotic-assisted minimally invasive surgery. Dr. Guthart joined Intuitive Surgical in April 1996 and has served... Read more

Beckman Coulter Diagnostics Receives CE Mark Clearance for its High-sensitivity Access hsTnI Assay

New assay enables hospitals to provide efficiency improvements in cardiac patient management BREA, CALIF. — (Nov 7, 2017) — Beckman Coulter Diagnostics announced today that it has received CE Mark clearance for a new high-sensitivity troponin (hsTnI) assay that aids in diagnosing myocardial infarction for patients presenting with chest pain or other ischemic symptoms. “The new,... Read more

QIAGEN reports results for third quarter and first nine months of 2017

Solid Q3 2017 performance in line with full-year ambitions: Net sales $364.0 million (+7% actual, +7% CER); adjusted net sales $364.4 million (+8% actual, +7% CER vs. +7% CER guidance) EPS $0.21; adjusted EPS $0.32 ($0.32 CER), adjusted EPS excluding restructuring charge $0.32 ($0.32 CER vs. $0.32-0.33 CER guidance) Nine-month 2017 free cash flow of... Read more